These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20156076)

  • 1. Metabolic syndrome does not predict an increased risk of coronary disease in patients with traditional risk factors referred for stress imaging study.
    Kamalesh M; Campbell S; Ligler L; Meda M; Eckert GJ; Sawada S
    Metab Syndr Relat Disord; 2010 Jun; 8(3):223-8. PubMed ID: 20156076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waist circumference and metabolic syndrome: the risk for silent coronary artery disease in males.
    Vakil KP; Malhotra S; Sawada S; Campbell SR; Sayfo S; Kamalesh M
    Metab Syndr Relat Disord; 2012 Jun; 10(3):225-31. PubMed ID: 22324791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography.
    Abdelmoneim SS; Basu A; Bernier M; Dhoble A; Abdel-Kader SS; Pellikka PA; Mulvagh SL
    Diab Vasc Dis Res; 2011 Oct; 8(4):254-61. PubMed ID: 21933841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome attenuates effect of chronic kidney disease on prevalence of coronary disease in men referred for stress imaging study.
    Kamalesh M; Campbell S; Chong CK; Gipson A; Patel N; Ng C; Eckert GJ; Meda M; Sawada S
    Clin Nephrol; 2009 Mar; 71(3):255-62. PubMed ID: 19281735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score.
    Konstantinou DM; Chatzizisis YS; Louridas GE; Giannoglou GD
    Metab Syndr Relat Disord; 2010 Jun; 8(3):201-8. PubMed ID: 20156070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study.
    Senior R; Moreo A; Gaibazzi N; Agati L; Tiemann K; Shivalkar B; von Bardeleben S; Galiuto L; Lardoux H; Trocino G; Carrió I; Le Guludec D; Sambuceti G; Becher H; Colonna P; Ten Cate F; Bramucci E; Cohen A; Bezante G; Aggeli C; Kasprzak JD
    J Am Coll Cardiol; 2013 Oct; 62(15):1353-61. PubMed ID: 23770168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
    Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and its contribution to coronary artery disease in non-diabetic subjects.
    Lin RT; Lee WJ; Jeng CY; Sheu WH; Chen YT
    J Formos Med Assoc; 2004 Apr; 103(4):317-20. PubMed ID: 15175831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis.
    Uthamalingam S; Zheng H; Leavitt M; Pomerantsev E; Ahmado I; Gurm GS; Gewirtz H
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):176-86. PubMed ID: 21329903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
    Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
    Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention].
    Mori T; Ohashi Y; Ejiri J; Takatsuki K; Ichikawa S; Awano K
    J Cardiol; 2005 Sep; 46(3):89-96. PubMed ID: 16218426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images.
    Emmett L; Magee M; Freedman SB; Van der Wall H; Bush V; Trieu J; Van Gaal W; Allman KC; Kritharides L
    J Nucl Med; 2005 Oct; 46(10):1596-601. PubMed ID: 16204708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute flow or myocardial flow reserve for the detection of significant coronary artery disease?
    Joutsiniemi E; Saraste A; Pietilä M; Mäki M; Kajander S; Ukkonen H; Airaksinen J; Knuuti J
    Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):659-65. PubMed ID: 24408930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signs and symptoms of suspected myocardial ischemia in women: results from the What is the Optimal Method for Ischemia Evaluation in WomeN? Trial.
    Mieres JH; Heller GV; Hendel RC; Gulati M; Boden WE; Katten D; Shaw LJ
    J Womens Health (Larchmt); 2011 Sep; 20(9):1261-8. PubMed ID: 21740192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of obstructive coronary disease in metabolic syndrome patients with abnormal stress echocardiography.
    Al Badarin FJ; From AM; McCully RB; Lopez-Jimenez F
    Int J Cardiol; 2011 Oct; 152(2):207-11. PubMed ID: 20674994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size.
    Hansen CL; Crabbe D; Rubin S
    J Am Coll Cardiol; 1996 Nov; 28(5):1214-9. PubMed ID: 8890818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic stress echocardiography detects coronary artery disease in patients with asymptomatic type II diabetes.
    Paraskevaidis IA; Tsougos E; Panou F; Dagres N; Karatzas D; Boutati E; Varounis C; Kremastinos DT
    Coron Artery Dis; 2010 Mar; 21(2):104-12. PubMed ID: 20124991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.